Study on the Drug Interactions of HRS-9813, Pirfenidone and Nintedanib in Healthy Subjects

Clinical trial NCT07229716 · RECRUITING

Trial details

NCT number: NCT07229716
Sponsor: Guangdong Hengrui Pharmaceutical Co., Ltd
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Pulmonary Fibrosis

Start date: 2026-04-04
Primary completion: 2026-05-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.